LDN Protects Bone Property Deterioration at Different Hierarchical Levels in T2DM Mice Bone (Abstract)

LDN Protects Bone Property Deterioration at Different Hierarchical Levels in T2DM Mice Bone ACS Omega 10 Aug 2021 https://pubmed.ncbi.nlm.nih.gov/34395985/ Type 2 diabetes mellitus (T2DM) commonly affects bone quality at different hierarchical levels and leads to an increase in the risk of bone fracture. Earlier, some anti-diabetic drugs showed positive effects on bone mechanical properties. Recently, […]

Dr Jill Cottel, LDN Radio Show 30 Nov 2016 (LDN, low dose naltrexone)

Dr Jill Cottel, LDN Radio Show 30 Nov 2016 (LDN, low dose naltrexone) from LDN Research Trust on Vimeo. Welcome Jill! How does it feel to be our first guest on the new LDN Radio Show? Dr Jill Cottel: Hello, Linda. It’s very exciting. Linda Elsegood:  Thank you! Isn’t amazing? I mean, you’re out there […]

Low dose naltrexone (LDN) enhances maturation of bone marrow dendritic cells (BMDCs) (Abstract)

Low dose naltrexone (LDN) enhances maturation of bone marrow dendritic cells (BMDCs) Int Immunopharmacol December 2013 https://www.ncbi.nlm.nih.gov/pubmed/24455776 It has been demonstrated previously that immune cell activation and proliferation were sensitive to the effects of naltrexone, a non-peptidic δ-opioid receptor selective antagonist and opioid receptors on BMDCs have been detected [1]. However, there is little prior […]